Amyloid drugs, a second look
New data reopen the debate over who benefits from anti-amyloid antibodies.
Clara Whitfield · 31 October 2026
Clinical trials, drug development and research news
Topic
The brain, the nervous system and the long road to new treatments.
New data reopen the debate over who benefits from anti-amyloid antibodies.
Clara Whitfield · 31 October 2026
The Briefing
One email. The week's readouts, approvals and research, explained without hype.